Cancer Genetics and Epigenetics 2024, Vol.12, No.6, 329-345 http://medscipublisher.com/index.php/cge 344 Salamini-Montemurri M., Lamas-Maceiras M., Lorenzo-Catoira L., Vizoso-Vázquez Á., Barreiro-Alonso A., Rodríguez-Belmonte E., Quindós-Varela M., and Cerdán M.E., 2023, Identification of lncRNAs deregulated in epithelial ovarian cancer based on a gene expression profiling meta-analysis, International Journal of Molecular Sciences, 24(13): 10798. https://doi.org/10.3390/ijms241310798 Šeborová K., Vaclavikova R., Rob L., Souček P., and Vodicka P., 2021, Non-coding RNAs as biomarkers of tumor progression and metastatic spread in epithelial ovarian cancer, Cancers, 13(8): 1839.. https://doi.org/10.3390/cancers13081839 PMID: 33921525 PMCID: PMC8069230 Sheng R., Li X.D., Wang Z.L., and Wang X.P., 2020, Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer, Cancer Letters, 473: 139-147. https://doi.org/10.1016/j.canlet.2019.12.043 PMID: 31904484 Slabý O., Laga R., and Sedláček O., 2017, Therapeutic targeting of non-coding RNAs in cancer, The Biochemical Journal, 474(24): 4219-4251. https://doi.org/10.1042/BCJ20170079 Slack F.J., and Chinnaiyan A.M., 2019, The role of Non-coding RNAs in oncology, Cell, 179(5): 1033-1055. https://doi.org/10.1016/j.cell.2019.10.017 PMID: 31730848 PMCID: PMC7347159 Sun L.C., Zhang H.F., and Gao P., 2021, Metabolic reprogramming and epigenetic modifications on the path to cancer, Protein and Cell, 13: 877-919. https://doi.org/10.1007/s13238-021-00846-7 PMID: 34050894 PMCID: PMC9243210 Syeda Z.A., Langden S.S.S., Munkhzul C., Lee M., and Song S.J., 2020, Regulatory mechanism of microRNA Expression in cancer, International Journal of Molecular Sciences, 21(5): 1723. https://doi.org/10.3390/ijms21051723 PMID: 32138313 PMCID: PMC7084905 Tao M., Zheng M., Xu Y.H., Ma S., Zhang W.W., and Ju S.Q., 2021, CircRNAs and their regulatory roles in cancers, Molecular Medicine, 27(1): 94. https://doi.org/10.1186/s10020-021-00359-3 PMID: 34445958 PMCID: PMC8393742 Thompson D., Lawrentschuk N., and Bolton D., 2023, New approaches to targeting epigenetic regulation in bladder cancer, Cancers, 15(6): 1856. https://doi.org/10.3390/cancers15061856 PMID: 36980741 PMCID: PMC10046617 Wang J.E., 2024, The application prospects of CRISPR-Cas9 technology in gene therapy, International Journal of Molecular Medical Science, 14(1): 8-15. https://doi.org/10.5376/ijmms.2024.14.0002 Wang Y., Huang Z., Li B.W., Liu L., and Huang C.H., 2022, The emerging roles and therapeutic implications of epigenetic modifications in ovarian cancer, Frontiers in Endocrinology, 13: 863541. https://doi.org/10.3389/fendo.2022.863541 PMID: 35620395 PMCID: PMC9127157 Wang Z.H., Yang B., Zhang M., Guo W.W., Wu Z.Y., Wang, Y., Jia L., Li S., Cancer Genome Atlas Research Network, Xie W., and Yang, D., 2018, lncRNA epigenetic landscape analysis identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes cell-cycle progression in cancer, Cancer Cell, 33(4): 706-720. https://doi.org/10.1016/j.ccell.2018.03.006 PMID: 29622465 PMCID: PMC6143179 Wei J.W., Huang, K., Yang, C., and Kang C.S., 2017, Non-coding RNAs as regulators in epigenetics (Review), Oncology reports, 37(1): 3-9. https://doi.org/10.3892/or.2016.5236 PMID: 27841002 Xiong Y.N., Dowdy S.C., Podratz K.C., Jin F., Attewell J.R., Eberhardt N.L., and Jiang S.W., 2005, Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells, Cancer Research, 65(7): 2684-2689. https://doi.org/10.1158/0008-5472.CAN-04-2843 Yang Q.L., Yang Y.Q., Zhou N.X., Tang K.X., Lau W.B., Lau B., Wang W., Xu L., Yang Z.N., Huang S., Wang X., Yi T., Zhao X., Wei Y.Q., Wang H.J., Zhao L.J., and Zhou, S.T., 2018, Epigenetics in ovarian cancer: premise, properties, and perspectives, Molecular Cancer, 17(1): 109. https://doi.org/10.1186/s12943-018-0855-4 PMID: 30064416 PMCID: PMC6069741 Zhang X.Z., Liu, H., and Chen S.R., 2020, Mechanisms of long non-coding RNAs in cancers and their dynamic regulations, Cancers, 12(5): 1245. https://doi.org/10.3390/cancers12051245 PMID: 32429086 PMCID: PMC7281179 Zhao H.M., Yu H.L., Zheng J.H., Ning N., Tang F.L., Yang Y., and Wang Y., 2018, Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5, Gynecologic Oncology, 151(2): 345-355. https://doi.org/10.1016/j.ygyno.2018.08.032
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==